Requirement/NN
of/IN
GATA-1/NN
and/CC
p45/NN
NF-E2/NN
expression/NN
in/IN
butyric/JJ
acid-induced/JJ
erythroid/JJ
differentiation/NN
./.

Butyric/JJ
acid/NN
(/(
BA/NN
)/)
is/VBZ
known/VBN
to/TO
induce/VB
overexpression/NN
of/IN
fetal/JJ
hemoglobin/NN
and/CC
then/RB
erythroid/JJ
differentiation/NN
./.
=====
Therefore/RB
,/,
BA/NN
is/VBZ
currently/RB
under/IN
clinical/JJ
investigation/NN
as/IN
a/DT
potential/JJ
therapy/NN
for/IN
the/DT
treatment/NN
of/IN
sickle/JJ
cell/NN
disease/NN
and/CC
cancer/NN
./.
=====
Nevertheless/RB
,/,
the/DT
molecular/JJ
mechanisms/NNS
involved/VBN
in/IN
BA-induced/JJ
differentiation/NN
remain/VBP
largely/RB
unknown/JJ
./.
=====
Previous/JJ
reports/NNS
have/VBP
shown/VBN
that/IN
BA-induced/JJ
overexpression/NN
of/IN
erythroid/JJ
genes/NNS
occurred/VBD
at/IN
the/DT
transcriptional/JJ
level/NN
,/,
suggesting/VBG
the/DT
involvement/NN
of/IN
erythroid/JJ
transcription/NN
factors/NNS
./.
=====
Here/RB
,/,
we/PRP
intend/VBP
to/TO
demonstrate/VB
the/DT
requirement/NN
of/IN
GATA-1/NN
and/CC
NF-E2/NN
transcription/NN
factors/NNS
in/IN
the/DT
BA-induced/JJ
erythroid/JJ
differentiation/NN
of/IN
human/JJ
leukemic/JJ
K562/NN
cells/NNS
./.
=====
Time-course/JJ
experiments/NNS
showed/VBD
that/IN
nuclear/JJ
levels/NNS
of/IN
GATA-1/NN
and/CC
p45/NN
NF-E2/NN
proteins/NNS
increased/VBD
during/IN
BA/NN
treatment/NN
./.
=====
Moreover/RB
,/,
antisense/JJ
oligodeoxynucleotides/NNS
targeting/VBG
either/CC
GATA-1/NN
or/CC
p45/NN
NF-E2/NN
proteins/NNS
inhibited/VBD
both/CC
protein/NN
expression/NN
and/CC
BA-induced/JJ
differentiation/NN
./.
=====
In/IN
contrast/NN
,/,
BA-induced/JJ
cell/NN
growth/NN
inhibition/NN
was/VBD
not/RB
affected/VBN
./.
=====
These/DT
results/NNS
provide/VBP
the/DT
first/JJ
direct/JJ
evidence/NN
for/IN
the/DT
requirement/NN
of/IN
GATA-1/NN
and/CC
NF-E2/NN
in/IN
BA-induced/JJ
differentiation/NN
process/NN
./.